STAT3 signalling in innate immune cells is required for the immunosuppressive and tumor-promoting effects of myeloid-derived suppressor cells (MDSCs) and tumor-associated macrophages (TAMs)[12–14]. The gene discussed is STAT3; the disease is neoplasm.